Considerations for choosing an optimal animal model of cardiovascular disease
Canadian Journal of Physiology and Pharmacology · 01.02.2024 · 102 (2) · 75-85
DOI: 10.1139/cjpp-2023-0206 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Physiology and Pharmacology, erschienen am 01.02.2024. Verfasst von Mihir Parikh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Hypertension, Atherosclerosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, CIHR Foundation.
Abstract (Originalsprache)
The decision to use the optimal animal model to mimic the various types of cardiovascular disease is a critical one for a basic scientist. Clinical cardiovascular disease can be complex and presents itself as atherosclerosis, hypertension, ischemia/reperfusion injury, myocardial infarcts, and cardiomyopathies, amongst others. This may be further complicated by the simultaneous presence of two or more cardiovascular lesions (for example, atherosclerosis and hypertension) and co-morbidities (i.e., diabetes, infectious disease, obesity, etc). This variety and merging of disease states creates an unusually difficult situation for the researcher who needs to identify the optimal animal model that is available to best represent all of the characteristics of the clinical cardiovascular disease. The present manuscript reviews the characteristics of the various animal models of cardiovascular disease available today, their advantages and disadvantages, with the goal to allow the reader access to the most recent data available for optimal choices prior to the initiation of the study. The animal species that can be chosen, the methods of generating these models of cardiovascular disease, as well as the specific cardiovascular lesions involved in each of these models are reviewed. A particular focus on the JCR:LA- cp rat as a model of cardiovascular disease is discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
- Institute of Cardiovascular Sciences, Albrechtsen Research Centre, St. Boniface Hospital, Winnipeg, MB, Canada.
ORCID-Profile: Grant N Pierce
Förderung
- CIHR
- CIHR Foundation
Zitieren
APA
Parikh, M., & Pierce, G. N. (2024). Considerations for choosing an optimal animal model of cardiovascular disease. Canadian Journal of Physiology and Pharmacology, 102(2), 75-85. https://doi.org/10.1139/cjpp-2023-0206
Vancouver
Parikh M, Pierce GN. Considerations for choosing an optimal animal model of cardiovascular disease. Canadian Journal of Physiology and Pharmacology. 2024;102(2):75-85. doi:10.1139/cjpp-2023-0206
BibTeX
@article{Parikh2024,
author = {Parikh, Mihir and Pierce, Grant N},
title = {Considerations for choosing an optimal animal model of cardiovascular disease},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2024},
volume = {102},
number = {2},
pages = {75--85},
doi = {10.1139/cjpp-2023-0206}
}
EUVIMED